We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

14 hedge funds and large institutions have $13.9M invested in Zosano Pharma Corporation in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more funds holding

Funds holding: 13 → 14 (+1)

4% more capital invested

Capital invested by funds: $13.4M → $13.9M (+$487K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$3.29K
2
Barclays
Barclays
United Kingdom
+$1.65K

Top Sellers

Rank Fund Capital Flow
1
LOAMU
Lombard Odier Asset Management (USA)
New York
-$44.4K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.5K
3
UBS Group
UBS Group
Switzerland
-$1.65K
4
Walleye Trading
Walleye Trading
New York
-$1.65K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$4.96M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$4.12M -$11.5K -7 -0.3%
EAM
3
Eventide Asset Management
Massachusetts
$2.04M – – –
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$1.1M -$44.4K -27 -4%
PI
5
Putnam Investments
Massachusetts
$920K – – –
SM
6
Sabby Management
Florida
$296K – – –
VC
7
Vivo Capital
California
$227K +$232K +141 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$208K – – –
KCM
9
Knoll Capital Management
Florida
$43K – – –
IA
10
IFP Advisors
Florida
$6K +$3.29K +2 New
BFA
11
BlackRock Fund Advisors
California
$3K – – –
BIM
12
BlackRock Investment Management
Delaware
$2K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$2K – – –
UBS Group
14
UBS Group
Switzerland
$1K -$1.65K -1 Closed
Walleye Trading
15
Walleye Trading
New York
$1K -$1.65K -1 Closed
Barclays
16
Barclays
United Kingdom
$1K +$1.65K +1 New

ZSAN Hedge Fund Activity: Q1 2016 in Review

14 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2016, worth a combined $13.9M — up 3.6% from $13.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ZSAN positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was IFP Advisors, opening a new position worth an estimated $3.29K. The largest seller was Lombard Odier Asset Management (USA), cutting an estimated $44.4K.

  • 14 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2016, up from 13 in Q4 2015.
  • Funds reported $13.9M of Zosano Pharma Corporation stock for Q1 2016, up 3.6% quarter-over-quarter.
  • 3 funds opened new Zosano Pharma Corporation positions in Q1 2016 and 2 closed out, a net change of +1 holder.
  • The largest Zosano Pharma Corporation buyer in Q1 2016 was IFP Advisors, an estimated $3.29K added.
  • The largest Zosano Pharma Corporation seller in Q1 2016 was Lombard Odier Asset Management (USA), an estimated $44.4K sold.

Based on aggregated 13F filings for Q1 2016.